Japan Approves LimFlow Study
Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved LimFlow's Clinical Trial Notification (CTN) for the Japanese cohort of the ongoing PROMISE II pivotal trial of the LimFlow Percutaneous Deep Vein Arterialization (pDVA) System. LimFlow SA, is a pioneer in the...
Latest News
'UK Healthcare Pavilion’ Partnership Gateway to Middle East
The UK Healthcare Pavilion – the first virtual platform showcasing the very best of UK...
read the full article >
Cardiology
First Patients in Europe Treated with Biosense Webster VARIPULSE® AF Catheter
Johnson & Johnson Medical Devices Companies' Biosense Webster, Inc., says the first patients...
read the full article >Approvals / Clearance
Clinical Studies / Trials
App Boost for BioTech Businesses
Berlin-based Biotech networking company A-LabInsider has created an app that is a resource listing...
read the full article >